Table 4.

Predictive Factors Associated with Rebleeding According to Univariate and Multivariate Regression Analyses

Measure	Univariate OR (95% CI)	p-value	Multivariate OR (95% CI)	p-value
Male sex	1.123 (0.622–2.028)	0.700
Age	1.027 (1.008–1.046)	0.005
Comorbidity	1.229 (0.661–2.286)	0.514	2.947 (1.298–6.691)	0.010
Systolic blood pressure	0.995 (0.984–1.007)	0.430
Pulse rate	0.997 (0.984–1.010)	0.651
Antiplatelet	1.766 (0.670–4.653)	0.250
Anticoagulant	1.491 (0.570–3.900)	0.415
NSAIDs	2.504 (1.366–4.588)	0.003
Steroids	3.738 (1.202–11.625)	0.023
Multidrug	4.224 (2.263–7.884)	0.000	3.105 (1.181–8.165)	0.022
Body mass index	0.929 (0.858–1.006)	0.070
Hemoglobin	0.981 (0.903–1.067)	0.659
White blood cell	1.000 (1.000–1.000)	0.910
Platelet	1.000 (1.000–1.000)	0.866
Blood urea nitrogen	1.003 (0.998–1.007)	0.218
Creatinine	0.994 (0.928–1.065)	0.873
Albumin	0.404 (0.262–0.622)	0.000	0.508 (0.305–0.846)	0.009
Experience (≥3 yr)	1.085 (0.635–1.851)	0.766
Weekends	1.238 (0.706–2.172)	0.456
Time to endoscopy	0.976 (0.923–1.033)	0.409
Hematemesis/hematochezia	2.145 (1.276–3.604)	0.004	1.882 (1.008–3.256)	0.024
Forrest classification high risk group	1.315 (0.746–2.318)	0.343
Monotherapy	0.927 (0.507–1.696)	0.806
Transfusion	2.037 (1.105–3.756)	0.023
Second look endoscopy	0.710 (0.299–1.689)	0.439
Helicobacter pylori infection	0.528 (0.278–1.003)	0.051

OR, odds ratio; CI, confidence interval; NSAID, nonsteroidal anti-inflammatory drug.